Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to Adaptation
Open Access
- 1 January 2002
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (1) , 233-238
- https://doi.org/10.1128/jcm.40.1.233-238.2002
Abstract
In immunocompromised patients with disseminated infection, human cytomegalovirus (HCMV) is widespread in the microvascular endothelium of multiple organs. Human umbilical vein endothelial cells (HUVEC) were used in parallel to human embryonic lung fibroblasts (HELF) to recover HCMV from blood samples of immunocompromised patients. Using the shell vial technique, comparable median numbers of p72-positive HUVEC and HELF cells were found with the 26 HCMV-positive buffy coat samples out of 150 examined. Analysis of other clinical samples inoculated as controls revealed, in the presence of highly infected HELF monolayers, either the presence of very few infected HUVEC with urine specimens (n = 10 samples) or the lack of infected HUVEC with throat washes (n = 3) or amniotic fluid samples (n = 2). Thus, peripheral blood leukocytes (PBL) appear essential for primary isolation of HCMV in HUVEC. In this respect, HCMV strains, recovered from clinical samples other than buffy coats in HELF only, could be readily adapted to growth in HUVEC by coculturing PBL from healthy blood donors with infected HELF and then inoculating infected PBL onto HUVEC. Recently elucidated mechanisms of interaction of leukocytes and HUVEC with bidirectional transfer of virus seem to provide the basis for the restriction of HCMV primary isolation in HUVEC to blood samples. However, virus strains recovered from only HELF could be adapted to growth in HUVEC when inoculated with HELF-derived (either cell-associated or cell-free) HCMV strains upon primary isolation. In conclusion, due to the in vitro selection of virus variants provided with both PBL tropism and HUVEC tropism, HCMV recovery in HUVEC is PBL mediated and substantially restricted to blood samples. Lack of HCMV recovery in HUVEC from clinical samples other than blood leads to the assumption that epithelial cells, such as urinary, amniotic, or pharyngeal cells, do not possess adequate adhesion molecules to establish close contacts with HUVEC.Keywords
This publication has 11 references indexed in Scilit:
- In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cellsJournal of General Virology, 2001
- Human Cytomegalovirus Replicates Abortively in Polymorphonuclear Leukocytes after Transfer from Infected Endothelial Cells via Transient Microfusion EventsJournal of Virology, 2000
- In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.Journal of Clinical Investigation, 1998
- Cytomegalovirus‐Infected Endothelial Cells Recruit Neutrophils by the Secretion of C‐X‐C Chemokines and Transmit Virus by Direct Neutrophil‐Endothelial Cell Contact and during Neutrophil Transendothelial MigrationThe Journal of Infectious Diseases, 1998
- Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissuesJournal of General Virology, 1995
- Bidirectional Transmission of Infectious Cytomegalovirus between Monocytes and Vascular Endothelial Cells: An In Vitro ModelThe Journal of Infectious Diseases, 1995
- Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.Journal of Clinical Investigation, 1993
- Circulating Cytomegalovirus (CMV)-Infected Endothelial Cells in Patients with an Active CMV InfectionThe Journal of Infectious Diseases, 1993
- Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteinsJournal of Clinical Microbiology, 1990
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989